DENOSUMAB solution for injection (Prolia®) for bone loss associated with long-term systemic glucocorticoid therapy - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

DENOSUMAB solution for injection (Prolia®) for bone loss associated with long-term systemic glucocorticoid therapy

Last Updated: 02 October 2018

Body System: Endocrine System

Grey

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of DENOSUMAB solution for injection (Prolia®) for the treatment of bone loss associated with long-term systemic glucocorticoid therapy.